Boehringer in research collaboration with Domain Therapeutics

04-12-2018

Boehringer in research collaboration with Domain Therapeutics

brauns / iStockphoto.com

German pharmaceutical company Boehringer Ingelheim has signed a research collaboration and licence agreement with French and Canadian biopharmaceutical business Domain Therapeutics.


Boehringer Ingelheim, Domain Therapeutics, research collaboration, licence agreement, Neuropsychiatry, proprietary technology, immuno-oncology

LSIPR